Range Resources Corporation (RRC)

Lumos Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 7, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	8,389	8,681	7,342	6,031	4,434	1,639
Market Cap Growth	19.51%	18.23%	21.75%	36.00%	170.54%	34.79%
Enterprise Value	9,732	10,232	8,971	8,271	7,410	4,758
Last Close Price	35.05	35.81	30.01	24.39	17.28	6.49
PE Ratio	17.81	32.75	8.58	5.22	11.06	-
Forward PE	9.20	13.63	11.51	4.90	4.61	9.52
PS Ratio	3.00	3.68	2.88	1.13	1.24	0.92
PB Ratio	2.03	2.21	1.95	2.10	2.13	1.00
P/TBV Ratio	2.02	2.21	1.95	2.10	2.13	1.00
P/FCF Ratio	16.49	27.48	19.79	4.38	11.85	-
P/OCF Ratio	7.39	9.19	7.51	3.23	5.59	6.10
PEG Ratio	0.51	13.63	0.43	0.20	0.66	6.33
EV/Sales Ratio	3.48	4.34	3.51	1.55	2.07	2.67
EV/EBITDA Ratio	9.05	13.18	5.19	3.96	7.55	12.88
EV/EBIT Ratio	14.02	24.98	6.73	4.84	12.14	-
EV/FCF Ratio	19.23	32.39	24.18	6.01	19.80	-
Debt / Equity Ratio	0.34	0.46	0.48	0.67	1.42	1.93
Debt / EBITDA Ratio	1.18	2.08	0.99	0.90	2.87	7.33
Debt / FCF Ratio	2.73	5.76	4.86	1.40	7.94	-
Asset Turnover	0.39	0.32	0.37	0.80	0.56	0.28
Quick Ratio	0.40	0.48	0.85	0.50	0.62	0.36
Current Ratio	0.55	0.57	1.49	0.53	0.64	0.41
Return on Equity (ROE)	12.02%	6.92%	26.23%	47.70%	22.12%	-35.72%
Return on Assets (ROA)	6.04%	3.52%	12.05%	16.07%	5.96%	-1.21%
Return on Capital (ROIC)	7.74%	4.52%	16.07%	21.65%	7.75%	-1.48%
Return on Capital Employed (ROCE)	10.60%	6.70%	20.10%	30.50%	11.10%	-
Earnings Yield	5.73%	3.07%	11.87%	19.62%	9.29%	-43.43%
FCF Yield	6.06%	3.64%	5.05%	22.83%	8.44%	-10.17%
Dividend Yield	1.02%	0.89%	1.07%	0.66%	-	-
Payout Ratio	17.17%	29.08%	8.87%	3.26%	-	-
Buyback Yield / Dilution	-0.48%	-1.21%	2.66%	1.18%	-3.29%	2.66%
Total Shareholder Return	0.55%	-0.32%	3.72%	1.83%	-3.29%	2.66%

Updated Jul 22, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q